Show simple item record

dc.contributor.authorEnnab, Farah
dc.contributor.authorElSaban, Mariam
dc.contributor.authorKhalaf, Eman
dc.contributor.authorTabatabaei, Hanieh
dc.contributor.authorHassan Khamis, Amar
dc.contributor.authorSaravanan, Ketharanathan
dc.contributor.authorCremonesini, David
dc.contributor.authorPopatia, Rizwana
dc.contributor.authorMalik, Zainab
dc.contributor.authorHo, Samuel B
dc.contributor.authorAbusamra, Rania
dc.date.accessioned2022-01-17T04:50:07Z
dc.date.available2022-01-17T04:50:07Z
dc.date.issued2021
dc.identifier.other204-2021.15
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/706
dc.description.abstractBackground: COVID-19 has infected over 123 million people globally. The first confirmed case in the United Arab Emirates (UAE) was reported on January 29, 2020. According to studies conducted in the early epicenters of the pandemic, COVID-19 has fared mildly in the pediatric population. To date, there is a lack of published data about COVID-19 infection among children in the Arabian region. Objective: This study aims to investigate the clinical characteristics, laboratory findings, treatment, and outcomes of children with COVID-19. Methods: This cross-sectional, multicenter study included children with confirmed COVID-19 infection admitted to 3 large hospitals in Dubai, UAE, between March 1 and June 15, 2020. Serial COVID-19 polymerase chain reaction (PCR) testing data were collected, and patients’ demographics, premorbid clinical characteristics, and inpatient hospital courses were examined. Results: In all, 111 children were included in our study and represented 22 nationalities. Of these, 59 (53.2%) were boys. The mean age of the participants was 7 (SD 5.3) years. About 15.3% of children were younger than 1 year. Only 4 (3.6%) of them had pre-existing asthma, all of whom had uneventful courses. At presentation, of the 111 children, 43 (38.7%) were asymptomatic, 68 (61.2%) had mild or moderate symptoms, and none (0%) had severe illness requiring intensive care. Fever (23/111, 20.7%), cough (22/111, 19.8%), and rhinorrhea (17/111, 15.3%) were the most common presenting symptoms, and most reported symptoms resolved by day 5 of hospitalization. Most patients had no abnormality on chest x-ray. The most common laboratory abnormalities on admission included variations in neutrophil count (22/111, 24.7%), aspartate transaminase (18/111, 22.5%), alkaline phosphatase (29/111, 36.7%), and lactate dehydrogenase (31/111, 42.5%). Children were infrequently prescribed targeted medications, with only 4 (3.6%) receiving antibiotics. None of the 52 patients tested for viral coinfections were positive. COVID-19 PCR testing turned negative at a median of 10 days (IQR: 6-14) after the first positive test. Overall, there was no significant difference of time to negative PCR results between symptomatic and asymptomatic children. Conclusions: This study of COVID-19 presentations and characteristics presents a first look into the burden of COVID-19 infection in the pediatric population in the UAE. We conclude that a large percentage of children experienced no symptoms and that severe COVID-19 disease is uncommon in the UAE. Various laboratory abnormalities were observed despite clinical stability. Ongoing surveillance, contact tracing, and public health measures will be important to contain future outbreaks.en_US
dc.language.isoenen_US
dc.subjectPediatricsen_US
dc.subjectChildrenen_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2en_US
dc.subjectUnited Arab Emiratesen_US
dc.subjectViral sheddingen_US
dc.subjectPandemicen_US
dc.subjectTreatmenten_US
dc.subjectOutcomesen_US
dc.subjectTreatment outcomesen_US
dc.subjectClinicalen_US
dc.subjectPublic heathen_US
dc.titleClinical Characteristics of Children with COVID-19 in the United Arab Emirates: Cross-sectional Multicenter Studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record